Sensyne Health Shares Fall on Financing Agreement to Continue Trading

- Advertisement -


by Anthony O’Goryinoff

- Advertisement -
- Advertisement -

Shares of Sensyne Health PLC fell on Friday when it said it had signed a financing deal with institutional shareholders for £6.4 million ($8.8 million) because without financing it is unlikely to continue trading in early February. Is.

Shares were down 35 pence, or 46%, at 40.50 pence at 0838 GMT.

- Advertisement -

The London-listed clinical artificial-intelligence company said the non-binding terms are for a loan note with an additional GBP5 million that can be provided by mutual consent, and it believes financing will proceed in the near term.

Sensyne said its formal sales process — first announced in November — has moved to the next stage, and multiple parties are in detailed discussions with the company.

The company said that its business-development pipeline continues to grow and, however, has faced significant business constraints, including delays in contracts, due to the impact of COVID-19 on pharmaceutical companies.

It added that these factors are slowing the conversion of its robust pipeline into commercial agreements.

Anthony O. Write to Goriainoff at [email protected]

,

- Advertisement -

Stay on top - Get the daily news in your inbox

DMCA / Correction Notice

Recent Articles

Related Stories

Stay on top - Get the daily news in your inbox